Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Peirong Lu

Peirong Lu

Director and Professor Department of Ophthalmology, the First Affiliated Hospital of Soochow University

Title: Secondary Multifocal Intraocular Lens Implantation in Patient with White Cataract

Biography

Biography: Peirong Lu

Abstract

White cataract occupies certain proportion in cataract patients in developing country. Most of the white cataracts have to give up the refractive IOL implantation because of the limited accuracy of the axis length and IOL power measurement. However, the white cataract patients also have the right to choice refractive IOL and obtain satisfied uncorrected distance and near visual acuity and spectacle independence after cataract surgery if we can detect the axis length precisely. To evaluate the outcomes of secondary multifocal intraocular lens (IOL) implantation in white cataract eyes, white cataract patients accepted secondary multifocal IOL implantation between June 2014 and January 2015 were retrospective reviewed. Ocular biometric parameters, surgical and visual outcomes were analyzed. Compared to conventional primary IOLs implantation, for the optimal white cataract patient, the white cataract were firstly extracted, following the optical biometry being precisely measured and also it is easy to identify whether the patient has adequate visual function, then the multifocal intraocular lens was secondary implanted. A total of five appropriate white cataract patients were enrolled in the secondary multifocal IOL implantation and were retrospective reviewed. The novel management strategy of secondary multifocal IOLs implantation were successful and without obvious adverse events. All the patients were achieved satisfied near and distance visual acuity and spectacle freedom. The outcomes suggest our novel management strategy is a safe and effective option for white cataract undergoing cataract surgery.